Typical Cost of Developing a New Drug Is Skewed by Few High-Cost Outliers
The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study.
photo</a> by <a href="https://flickr.com/photos/sgregory35/">Scott Gregory</a>/<a href="https://creativecommons.org/licenses/by-nd/2.0/">CC BY-ND 2.0</a>"/>